Advances in environmental epidemiology
Identifieur interne : 001E62 ( Main/Exploration ); précédent : 001E61; suivant : 001E63Advances in environmental epidemiology
Auteurs : Caroline M. Tanner [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2010.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Animals, Disease Models, Animal, Environment, Epidemiology, Health Status, Humans, Nervous system diseases, Neuroprotective Agents (therapeutic use), Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Parkinson Disease (etiology), Parkinson Disease (genetics), Parkinson disease, Parkinson's disease, Risk Factors, complex disease, environment, epidemiology.
- MESH :
- chemical , therapeutic use : Neuroprotective Agents.
- drug therapy : Parkinson Disease.
- epidemiology : Parkinson Disease.
- etiology : Parkinson Disease.
- genetics : Parkinson Disease.
- Animals, Disease Models, Animal, Environment, Health Status, Humans, Risk Factors.
Abstract
Parkinson's disease (PD) is likely due to the combined effects of environment and genes in most cases. Environmental factors inversely associated with PD (or, putative protective factors) include cigarette smoking, use of coffee/caffeine, higher uric acid levels, and anti‐inflammatory drug use. Less well‐established inverse associations with PD include higher cholesterol levels, statin use, higher dietary vitamin B6, and night shift work. Putative risk factors are pesticide exposure, head trauma, certain occupations, and milk consumption. The pathogenesis of PD may begin decades before motor symptoms. PD may have shared determinants with other neurodegenerative disorders involving abnormal protein aggregation. © 2010 Movement Disorder Society
Url:
DOI: 10.1002/mds.22721
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002B58
- to stream Istex, to step Curation: 002B58
- to stream Istex, to step Checkpoint: 000B41
- to stream PubMed, to step Corpus: 001940
- to stream PubMed, to step Curation: 001940
- to stream PubMed, to step Checkpoint: 001A52
- to stream Ncbi, to step Merge: 002A62
- to stream Ncbi, to step Curation: 002A62
- to stream Ncbi, to step Checkpoint: 002A62
- to stream Main, to step Merge: 002298
- to stream PascalFrancis, to step Corpus: 000C01
- to stream PascalFrancis, to step Curation: 002118
- to stream PascalFrancis, to step Checkpoint: 000C14
- to stream Main, to step Merge: 002801
- to stream Main, to step Curation: 001E62
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Advances in environmental epidemiology</title>
<author><name sortKey="Tanner, Caroline M" sort="Tanner, Caroline M" uniqKey="Tanner C" first="Caroline M." last="Tanner">Caroline M. Tanner</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BCC11EA9EE30F1DE4121BBC49BDDB14EC1DB6CCD</idno>
<date when="2010" year="2010">2010</date>
<idno type="doi">10.1002/mds.22721</idno>
<idno type="url">https://api.istex.fr/document/BCC11EA9EE30F1DE4121BBC49BDDB14EC1DB6CCD/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002B58</idno>
<idno type="wicri:Area/Istex/Curation">002B58</idno>
<idno type="wicri:Area/Istex/Checkpoint">000B41</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Tanner C:advances:in:environmental</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:20187243</idno>
<idno type="wicri:Area/PubMed/Corpus">001940</idno>
<idno type="wicri:Area/PubMed/Curation">001940</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001A52</idno>
<idno type="wicri:Area/Ncbi/Merge">002A62</idno>
<idno type="wicri:Area/Ncbi/Curation">002A62</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002A62</idno>
<idno type="wicri:Area/Main/Merge">002298</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:10-0193327</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000C01</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002118</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000C14</idno>
<idno type="wicri:doubleKey">0885-3185:2010:Tanner C:advances:in:environmental</idno>
<idno type="wicri:Area/Main/Merge">002801</idno>
<idno type="wicri:Area/Main/Curation">001E62</idno>
<idno type="wicri:Area/Main/Exploration">001E62</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Advances in environmental epidemiology</title>
<author><name sortKey="Tanner, Caroline M" sort="Tanner, Caroline M" uniqKey="Tanner C" first="Caroline M." last="Tanner">Caroline M. Tanner</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Clinical Research, The Parkinson's Institute, Sunnyvale, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2010">2010</date>
<biblScope unit="vol">25</biblScope>
<biblScope unit="issue">S1</biblScope>
<biblScope unit="page" from="S58">S58</biblScope>
<biblScope unit="page" to="S62">S62</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BCC11EA9EE30F1DE4121BBC49BDDB14EC1DB6CCD</idno>
<idno type="DOI">10.1002/mds.22721</idno>
<idno type="ArticleID">MDS22721</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Environment</term>
<term>Epidemiology</term>
<term>Health Status</term>
<term>Humans</term>
<term>Nervous system diseases</term>
<term>Neuroprotective Agents (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson Disease (etiology)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Risk Factors</term>
<term>complex disease</term>
<term>environment</term>
<term>epidemiology</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Neuroprotective Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Environment</term>
<term>Health Status</term>
<term>Humans</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Environnement</term>
<term>Epidémiologie</term>
<term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is likely due to the combined effects of environment and genes in most cases. Environmental factors inversely associated with PD (or, putative protective factors) include cigarette smoking, use of coffee/caffeine, higher uric acid levels, and anti‐inflammatory drug use. Less well‐established inverse associations with PD include higher cholesterol levels, statin use, higher dietary vitamin B6, and night shift work. Putative risk factors are pesticide exposure, head trauma, certain occupations, and milk consumption. The pathogenesis of PD may begin decades before motor symptoms. PD may have shared determinants with other neurodegenerative disorders involving abnormal protein aggregation. © 2010 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Tanner, Caroline M" sort="Tanner, Caroline M" uniqKey="Tanner C" first="Caroline M." last="Tanner">Caroline M. Tanner</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E62 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E62 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:BCC11EA9EE30F1DE4121BBC49BDDB14EC1DB6CCD |texte= Advances in environmental epidemiology }}
This area was generated with Dilib version V0.6.23. |